# Straight answers about sore joints and treatment *Regenerative Medicine Glendale | Straight Joint Questions* > Regenerative medicine Glendale questions answered in plain words, from joint soreness and cartilage to nearby care. Glendale's dry afternoons can leave you tired before a sore joint enters the bargain. These answers cover what may be causing the ache and what you can do next. They can't tell you exactly what is wrong without an exam. Use them to make your next talk shorter and clearer. Bring the question that has been bothering you. ## Sources 1. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other. Eckstein F, et al. — [Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.](https://pubmed.ncbi.nlm.nih.gov/33962962/). *Annals of the rheumatic diseases*, 2021. DOI: 10.1136/annrheumdis-2020-219181. 2. OA-11, a 56-week phase 3 double-blind placebo-controlled trial, randomized 513 knee OA patients (KL 2-3) to a single intra-articular injection of the Wnt-pathway modulator lorecivivint or vehicle placebo. Lorecivivint MISSED its primary endpoint: 12-week pain NRS change was -2.24 with drug versus -2.49 with placebo (p=0.185), no other endpoint showed a discernible treatment effect, and neither group lost meaningful medial joint space over 52 weeks. Even a purpose-built, well-funded disease-modifying candidate has not beaten a placebo injection. Yazici Y, et al. — [A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/39808286/). *Clinical and experimental rheumatology*, 2025. DOI: 10.55563/clinexprheumatol/hjt118. 3. The phase II trial of lorecivivint (SM04690), an intra-articular CLK2/DYRK1A inhibitor and Wnt-pathway modulator, is the reference for how a genuine disease-modifying osteoarthritis DRUG is developed - defined molecule, defined target, dose-ranging, radiographic endpoints - which is the standard against which an unstandardised autologous injectate should be read. Yazici Y, et al. — [Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.](https://pubmed.ncbi.nlm.nih.gov/32432388/). *Arthritis & rheumatology (Hoboken, N.J.)*, 2020. DOI: 10.1002/art.41315. 4. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA*, 2020. 5. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 6. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit. Awad G, et al. — [Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/41863718/). *Clinical rheumatology*, 2026. DOI: 10.1007/s10067-026-08042-w. ## Is there a drug that can stop osteoarthritis getting worse? A disease modifying osteoarthritis drug is meant to slow joint damage, not merely quiet soreness. Research drugs have changed some joint measurements, but they haven't clearly improved both the joint and daily comfort. There isn't a routine drug that can promise to stop the wear. Ask your own doctor what care fits the joint you have now. ## What is regenerative medicine? In joint care, regenerative medicine describes choices prepared with blood or another material from the body. The name doesn't prove that cartilage will return. The goal may be less soreness or easier movement. An exam still comes first because the cause and amount of joint wear matter. ## Does regenerative medicine work for knees? Results differ by the product and the knee. Some people report less soreness, while stronger comparisons haven't always found a clear gain. A knee that is mildly worn isn't the same as one that gives way or has lost much of its joint space. Ask what result is realistic for your daily walking. ## How is platelet-rich plasma prepared? The clinic separates platelets from a sample of your blood and concentrates them. This is called PRP. The prepared material is then used at the sore joint. Clinics don't all prepare it the same way, and results aren't certain. Ask what is being used, what the visit involves, and how the clinic judges the result. ## Can joint regeneration or cartilage regeneration rebuild a worn joint? Those terms sound stronger than the evidence. Cartilage puts a slick layer over bone ends inside the joint, but it doesn't readily repair itself, and a person may feel better even when a scan stays the same. Don't take relief as proof that new cartilage formed. A scan number can't promise that your day will improve. ## What if my joint soreness doesn't settle? QC Kinetix offers a consultation about regenerative treatments that use your blood or another material from the body. Its medical providers are licensed clinic staff who examine and treat you. Bring your medicine names, old X-ray report, and notes on what makes the joint hurt. You'll still decide what makes sense after the exam. ## What can I do at home for joint soreness? Try lighter activity, easy movement, and a warm or cold pack if it feels good. Don't push through sharp pain. A cane or brace may steady some joints. Ask your own doctor or nurse before adding medicine, since your other medicines and health concerns matter. ## What usually makes an older joint feel worse? Too much work can stir the ache, but complete rest may add stiffness. Long sitting, stairs, hard floors, and lifting can bother different joints. Your notes can help. Write down what you were doing, where it hurt, and how long the soreness lasted. ## How much does regenerative medicine cost in Arizona? There isn't one set price because the choices and visit plans differ. Ask for the whole cost before agreeing, including any return visits. Don't risk money needed for food, housing, or medicine on an unclear promise. A clinic quote matters more than a broad Arizona estimate. ## Are regenerative medicine clinics in Arizona regulated differently? Regenerative medicine is still health care, and the same need for clear answers applies. Ask who examines you, what will be used, and what risks come with it. Don't let the word natural end the discussion. Your own doctor can help review a choice when you aren't sure. ## An exam can help when soreness stays Tell the licensed clinic staff where it hurts, when it began, and what you've tried. Bring your medicine names and any old joint reports. Book a free consultation: --- Straight help for a sore joint in Glendale. See why a joint aches, steps you can try, warning signs, and regenerative choices near Glendale. Clear guidance on aching joints, simple care, warning signs, and nearby visits for Glendale readers. This Glendale evidence desk is operated by the same owners who run the QC Kinetix Phoenix-area clinics it recommends. © 2026 Glendale Regen Monitor. Educational information only; individual decisions require medical assessment.